Redox Competitive Intelligence & Landscape

Redox is a leading healthcare technology company specializing in data interoperability and seamless data exchange within the healthcare industry. Its platform connects providers, payers, electronic health records (EHRs), health tech vendors, and life sciences organizations, enabling real-time data sharing to improve patient care, optimize workflows, and accelerate billing processes (redoxengine.com). The company boasts a vast network with over 12,000 connected healthcare organizations and handles more than 19 billion healthcare data transactions annually, demonstrating its significant role in healthcare data integration (redoxengine.com).

Founded in 2014 and headquartered in Madison, Wisconsin, Redox's core mission is to simplify healthcare data interoperability, making it easier for organizations to exchange and utilize health information securely and efficiently (redoxengine.com). The company's value proposition centers on providing a scalable, secure, and reliable platform that supports a wide range of healthcare applications, including analytics, AI workflows, and cloud integrations, with a focus on improving healthcare outcomes and operational efficiency (redoxengine.com). As a recognized leader in healthcare interoperability, Redox partners with major cloud providers like AWS, Google Cloud, and Microsoft Azure, further emphasizing its strategic role in advancing healthcare technology infrastructure (redoxengine.com).

Redox offers a variety of pricing plans tailored to different organizational needs, primarily focusing on custom quotes rather than fixed tiers. According to recent sources, there is no publicly listed free tier for Redox, but they do provide a free demo and the option to get a customized quote based on specific requirements (TrustRadius, Saascounter).

The platform's pricing is generally based on the scale and complexity of integration needs, with median costs around $45,750 annually, according to Vendr, which aggregates data from multiple purchases (Vendr). Some sources mention that Redox's pricing involves negotiation and varies depending on the size of the organization and the extent of services required (SoftwareSuggest).

While specific tier details are not publicly disclosed, Redox emphasizes flexible, custom solutions for enterprise clients, including options for full control, scalability, and security features. For precise pricing, organizations are encouraged to contact Redox directly for a tailored quote (Redox).

As of April 2026, Redox continues to demonstrate a strong hiring momentum, with a focus on expanding its team across various departments, including sales, engineering, and customer success. Recent job postings highlight ongoing recruitment efforts, particularly for remote roles such as Senior Technical Account Managers, Software Engineers, and Sales Directors, indicating a strategic emphasis on growth and market expansion (Redox Engine, Redox).

While specific layoffs are not reported in the available sources, the company's active recruitment and consistent posting of new openings suggest a positive outlook and a strategic approach to scaling operations rather than downsizing. The emphasis on hiring for roles like enterprise sales and technical management signals a focus on strengthening customer relationships and technological capabilities, aligning with a long-term growth strategy (QED Investors, Redox Lever).

Overall, Redox's hiring patterns reflect a company committed to innovation and expansion within the healthcare interoperability space, leveraging remote work to tap into a broader talent pool. The consistent posting of high-level roles such as Sales Directors and Software Engineers indicates a strategic focus on scaling its platform and market reach, which bodes well for its future growth trajectory.

Redox has demonstrated strong financial activity since its founding in 2014. The company has raised approximately $95 million in total funding across seven rounds, with the latest funding round amounting to $45 million as of early 2021 (Tracxn). Its valuation details are not publicly disclosed, but the company is considered a soonicorn, indicating a high valuation in the private market (Tracxn).

In terms of revenue, Redox is estimated to generate around $39 million annually, with its primary focus on healthcare data interoperability through a cloud-based platform that connects healthcare organizations and technology vendors (CompWorth). The company’s financial health shows a net profit of approximately -$392,920 USD as of December 2023, indicating it is still in growth and investment phases (The Company Check).

Redox has also engaged in M&A activity, although specific acquisitions are not detailed in the available sources. Its strategic investments and funding rounds suggest a focus on expanding its healthcare interoperability network and technological capabilities, positioning it as a significant player in the digital health industry (Clay, CompWorth). Overall, Redox remains financially robust with substantial funding backing its growth trajectory, despite ongoing operational losses.

Redox Technologies actively participates in a variety of industry events, conferences, and webinars focused on redox chemistry and related technologies. Notably, they are involved in the International Conference on Artificial Intelligence for Photocatalysis and AOTs, scheduled for May 18-21, 2026, at the University of Twente in the Netherlands, which covers topics at the intersection of catalysis and intelligence (Redox Technologies). Additionally, they are associated with the International Conference on Semiconductor Photocatalysis and Solar Energy Conversion and the Advanced Oxidation Technologies for Treatment of Water, Air, and Soil, both set for the same dates and venue, emphasizing their engagement in cutting-edge research and industry discussions (Redox Technologies).

Furthermore, Redox Flow is involved in the Hydrogen Technology World Expo 2026 held in Hamburg, Germany, from October 21-23, 2025, where they showcase their innovations and collaborate with other industry leaders (Hydrogen World Expo). They also sponsor and attend webinars such as the Molecules Webinar on recent advances in redox-active species, held on November 28, 2024, which highlights their commitment to ongoing education and community engagement in redox science (SciForum). These events demonstrate Redox Technologies’ active role in fostering innovation, networking, and knowledge exchange within the redox community.